Neuronetics Statistics

Total Valuation

Neuronetics has a market cap or net worth of $92.46 million. The enterprise value is $155.23 million.

Market Cap	92.46M
Enterprise Value	155.23M

Important Dates

The last earnings date was Tuesday, November 4, 2025, before market open.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Neuronetics has 68.49 million shares outstanding. The number of shares has increased by 95.24% in one year.

Current Share Class	68.49M
Shares Outstanding	68.49M
Shares Change (YoY)	+95.24%
Shares Change (QoQ)	+1.71%
Owned by Insiders (%)	12.30%
Owned by Institutions (%)	31.11%
Float	38.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.60
Forward PS	0.56
PB Ratio	3.38
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.24, with a Debt / Equity ratio of 2.89.

Current Ratio	2.24
Quick Ratio	1.62
Debt / Equity	2.89
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.24

Financial Efficiency

Return on equity (ROE) is -218.99% and return on invested capital (ROIC) is -25.85%.

Return on Equity (ROE)	-218.99%
Return on Assets (ROA)	-21.21%
Return on Invested Capital (ROIC)	-25.85%
Return on Capital Employed (ROCE)	-31.98%
Revenue Per Employee	$181,387
Profits Per Employee	-$62,154
Employee Count	716
Asset Turnover	1.18
Inventory Turnover	13.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.89% in the last 52 weeks. The beta is 0.71, so Neuronetics's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	+14.89%
50-Day Moving Average	2.35
200-Day Moving Average	3.52
Relative Strength Index (RSI)	31.20
Average Volume (20 Days)	2,099,183

Short Selling Information

The latest short interest is 6.52 million, so 9.52% of the outstanding shares have been sold short.

Short Interest	6.52M
Short Previous Month	5.53M
Short % of Shares Out	9.52%
Short % of Float	16.79%
Short Ratio (days to cover)	4.06

Income Statement

In the last 12 months, Neuronetics had revenue of $129.87 million and -$44.50 million in losses. Loss per share was -$0.77.

Revenue	129.87M
Gross Profit	66.10M
Operating Income	-37.27M
Pretax Income	-44.61M
Net Income	-44.50M
EBITDA	-34.21M
EBIT	-37.27M
Loss Per Share	-$0.77

Full Income Statement

Balance Sheet

The company has $27.97 million in cash and $90.75 million in debt, giving a net cash position of -$62.78 million or -$0.92 per share.

Cash & Cash Equivalents	27.97M
Total Debt	90.75M
Net Cash	-62.78M
Net Cash Per Share	-$0.92
Equity (Book Value)	31.36M
Book Value Per Share	0.40
Working Capital	35.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.88 million and capital expenditures -$674,000, giving a free cash flow of -$30.55 million.

Operating Cash Flow	-29.88M
Capital Expenditures	-674,000
Free Cash Flow	-30.55M
FCF Per Share	-$0.45

Full Cash Flow Statement

Margins

Gross margin is 50.89%, with operating and profit margins of -28.69% and -34.27%.

Gross Margin	50.89%
Operating Margin	-28.69%
Pretax Margin	-34.35%
Profit Margin	-34.27%
EBITDA Margin	-26.34%
EBIT Margin	-28.69%
FCF Margin	n/a

Dividends & Yields

Neuronetics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-95.24%
Shareholder Yield	-95.24%
Earnings Yield	-48.13%
FCF Yield	-33.04%

Analyst Forecast

The average price target for Neuronetics is $7.00, which is 418.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	418.52%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	26.46%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Neuronetics has an Altman Z-Score of -3.01 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.01
Piotroski F-Score	2